Northern Trust’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.6K Hold
10,857
﹤0.01% 4351
2025
Q1
$13.4K Sell
10,857
-43,299
-80% -$53.3K ﹤0.01% 4372
2024
Q4
$168K Buy
54,156
+21,703
+67% +$67.5K ﹤0.01% 4037
2024
Q3
$91.5K Sell
32,453
-928
-3% -$2.62K ﹤0.01% 4079
2024
Q2
$181K Sell
33,381
-1,442
-4% -$7.83K ﹤0.01% 3894
2024
Q1
$150K Sell
34,823
-3,888
-10% -$16.7K ﹤0.01% 3975
2023
Q4
$213K Buy
38,711
+27,830
+256% +$153K ﹤0.01% 3878
2023
Q3
$49.4K Hold
10,881
﹤0.01% 4171
2023
Q2
$33.7K Hold
10,881
﹤0.01% 4305
2023
Q1
$7.73K Sell
10,881
-2
-0% -$1 ﹤0.01% 4543
2022
Q4
$28.9K Hold
10,883
﹤0.01% 4404
2022
Q3
$40K Hold
10,883
﹤0.01% 4384
2022
Q2
$36K Hold
10,883
﹤0.01% 4500
2022
Q1
$48K Hold
10,883
﹤0.01% 4542
2021
Q4
$103K Hold
10,883
﹤0.01% 4412
2021
Q3
$184K Sell
10,883
-586
-5% -$9.91K ﹤0.01% 4215
2021
Q2
$320K Sell
11,469
-22,037
-66% -$615K ﹤0.01% 3903
2021
Q1
$750K Sell
33,506
-1,392
-4% -$31.2K ﹤0.01% 3689
2020
Q4
$506K Buy
34,898
+725
+2% +$10.5K ﹤0.01% 3724
2020
Q3
$513K Sell
34,173
-2,816
-8% -$42.3K ﹤0.01% 3599
2020
Q2
$766K Buy
36,989
+2,967
+9% +$61.4K ﹤0.01% 3439
2020
Q1
$647K Buy
34,022
+1,097
+3% +$20.9K ﹤0.01% 3383
2019
Q4
$948K Buy
32,925
+86
+0.3% +$2.48K ﹤0.01% 3416
2019
Q3
$1.68M Buy
32,839
+20,517
+167% +$1.05M ﹤0.01% 3197
2019
Q2
$976K Buy
12,322
+6,845
+125% +$542K ﹤0.01% 3367
2019
Q1
$361K Sell
5,477
-95
-2% -$6.26K ﹤0.01% 3617
2018
Q4
$309K Buy
5,572
+3,952
+244% +$219K ﹤0.01% 3665
2018
Q3
$147K Sell
1,620
-463
-22% -$42K ﹤0.01% 3938
2018
Q2
$197K Buy
+2,083
New +$197K ﹤0.01% 3860